Ke Li

Ke Li serves as a Postdoctoral Associate at Yale School of Public Health, focusing on cutting-edge research at the intersection of immunology, extracellular vesicles, and therapeutic applications. With numerous publications through 2025, Dr. Li's work spans multiple disciplines with particular emphasis on the therapeutic potential of exosomes and extracellular vesicles in various immune-mediated conditions.

Research interests center on extracellular vesicles as precision therapeutics, with significant contributions to understanding their role in hypersensitivity reactions, neuroimmunology, and pandemic response. Dr. Li's work demonstrates how mesenchymal stromal cell-derived exosomes can target specific immune cells, modulate immune responses, and potentially treat conditions ranging from contact dermatitis to long COVID encephalopathies. The research program integrates molecular biology, immunology, and systems approaches to understand vesicle-mediated cell communication.

Analysis of recent publications reveals a clear trajectory toward clinical applications of extracellular vesicles, with increasing focus on neuroimmunological conditions and pandemic-related pathologies. The work demonstrates sophisticated understanding of how exosomes carry specific miRNAs to targeted cells, with implications for precision medicine approaches in immunology and neurology.

Dr. Li's research program appears to be actively supported through institutional resources at Yale School of Public Health, with collaborations spanning immunology, neuroscience, and infectious disease research. The work shows strong translational potential with multiple therapeutic applications currently under investigation, particularly in the areas of neuroimmunology and post-viral syndromes.